CLINICAL_TRIALS
trial_result
· 2025-10-14
Clinical Trial Update: A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine [Phase 1]
Summary
A Phase 1 trial evaluating Lu AG09222 in combination with ubrogepant for migraine has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: H. Lundbeck A/S | Conditions: Migraine | Phase 1 | Status: COMPLETED